Exciting News!! We are thrilled to announce that a co-authored paper by our CSO, Prof. Takamasa Sakai and CTO, Dr. Hiroyuki Kamata, has been published in the Polymer Journal! The paper, titled "Optimizing a self-solidifying hydrogel as an endoscopically deliverable hydrogel coating system: a proof-of-concept study on porcine endoscopic submucosal dissection-induced ulcers," marks a significant milestone in our research and development efforts in the field of gastrointestinal endoscopy. At Gellycle, we are committed to advancing innovation and collaborating on cutting-edge research. If your company or research team is interested in exploring collaborative opportunities, please reach out. For more information: https://lnkd.in/eEPcQUJQ #gellycle #tetragel #hydrogel #research #development #innovation #gastroenterology #endoscopy #collaboration #PolymerJournal
概要
私たちは、「テトラゲル」を医療や工業に応用するために設立されたゲルテクノロジー企業です。このテトラゲルは、東京大学工学部の酒井教授によって発見・開発されました。私たちのテトラゲルは、世界で最も物性をコントロールできるゲルです。すでに人工靭帯、止血材、癒着防止剤などに応用可能な様々なゲルを開発しています。
- ウェブサイト
-
https://gellycle.com/home-en
ジェリクル株式会社の外部リンク
- 業種
- 医療機器製造業
- 会社規模
- 社員 11 - 50名
- 本社
- Tokyo、Tokyo
- 種類
- 非上場企業
- 創立
- 2018
- 専門分野
- Gel Technology、Tetra Gel、DDS、Regenerative Medicine、Hydro Gel、Artificial Ligament、Hemostasis
場所
-
プライマリ
3-38-10, Hongo, Bunkyo-ku
Tokyo、Tokyo、1130033、JP
ジェリクル株式会社の社員
-
Kosuke Masui
Gellycle -Founder and CEO | Bio Startup | Serial Entrepreneur | Berkeley SkyDeck (Batch17)
-
鎌田 宏幸
最高技術責任者 (CTO) at ジェリクル株式会社
-
Audrey Chan
Biology Economics @ UC Berkeley
-
Yoshihiro Okuno
Gellycle Co., Ltd. - Coordinator. Research and development of Gel Medicine with the usage of tetra-gel technology.
アップデート
-
ジェリクル株式会社さんが再投稿しました
🚨 BREAKING NEWS 🚨 🤑 Gellycle Co., Ltd. Batch 17, IPP) has secured $1M in funding from the Japan Agency for Medical Research and Development (AMED) to further develop their hydrogel for tendon regeneration. 🏥 Their technology aims to treat the after effects of ruptured finger tendons, increasing mobility after suturing. 🔗 Learn more here: https://lnkd.in/d3eR_UtZ #innovation #startup #medicine Hiroyuki Kamata Yoshihiro OKUNO
-
Join us at PharmaLab EXPO Tokyo from June 26 to 28!🇯🇵 ♯PharmaLabTokyo is the hub for the latest technologies and trends in the pharmaceutical industry. Can't wait to connect with peers and discover groundbreaking solutions. Read for more information: https://lnkd.in/eDgVrbMX ♯PharmaLabEXPO ♯Tokyo ♯Pharmaceuticals ♯Innovation ♯Healthcare ♯Research ♯Biotechnology ♯R&D ♯PharmaIndustry ♯Networking ♯MedicalDevices ♯Bioengineering
-
We were invited to Blue Knight Symposium by Johnson & Johnson as a proud member of Jlab in San Diego, US!🇺🇸 This premier event brings together top professionals, thought leaders, and innovators for insightful discussions, networking opportunities, and transformative learning experiences. Read for more information: https://lnkd.in/ezkmxTAr
-
Gellycle has been selected by Resona Bank, Ltd. (Head Office: Osaka City, Osaka; President: Shoichi Iwanaga) as an exhibitor in the Osaka Healthcare Pavilion Exhibition at the World Expo 2025 in Osaka, Kansai. This opportunity is part of the "Resona Mirai Color" project. Click here for press release; https://lnkd.in/eCbbGcmR At the pitch event held by Resona Bank on January 16, 2024, Gellycle was chosen based on the "attractiveness of the exhibition proposal/idea," "innovation and competitive advantage," "social significance (sustainability and social impact)," and "feasibility." We are honored to have this opportunity to showcase our advancements and contribute to the future of healthcare. 【What is the Osaka Healthcare Pavilion】 Under the theme of "REBORN," the Osaka Healthcare Pavilion aims to (1) bring together the wisdom and ideas of all of Osaka to create new values for the future society from the perspective of "life" and "health" and (2) clarify the image of "SDG Advanced City" to contribute to achieving the SDGs, and communicate our efforts toward the achievement of the SDG targets beyond 2030. Click here for more; https://lnkd.in/gwZ5zwa
-
Gellycle is attending BIO International Convention 2024 in San Diego as a member of Japan pavilion from JETRO Startup!🇺🇸 Reach out to Yoshihiro Okuno and Ryo Inagaki for further information. Check out more about the event at https://lnkd.in/e-BYfmig and about Gellycle at https://lnkd.in/ehyMqYZc . #BioInternationalConvention #BioInternationalConvention2024 #JapanPavilion #biotech #biotechnology #JETRO #Gellycle #TetraGel #HydroGel #TetraGelTechnology #TheUniversityofTokyo #Japan #Tokyo #JapaneseTechnology #RD #health #healthcare #platform #medical #medicalcare
-
We are thrilled to be part of Swiss Biotech Day on April 22nd-23rd!🇨🇭 Yuta Harako and Ryo Inagaki will be there to represent our Tetra-Gel Technology invented by Prof. Sakai from The University of Tokyo. Looking forward to seeing you in Basel! #swissbiotechday #tetragel #gellycle
-
Gellycle is attending Medtech Japan 2024! 🎌 Join us from April 17th to 19th at Tokyo Big Sight East Hall as we unveil the latest innovative Tetra-Gel Technology. Kosuke Masui, Yoshihiro Okuno, and Manami Iso will proudly be representing Gellycle Co., Ltd. at the Exhibition. Swing by our booth #1502 to explore the future of innovation.💧 We hope to see you soon! #MedtechJapan2024 #TetraGel #Gellycle
-
Gellycle will exhibit at "PharmaLab Expo 2024" in Osaka, from March 13 to 15. We are actively looking for partners worldwide to collaborate with our gel technology! https://lnkd.in/gHKwMjAj
Event
gellycle.com
-
Macromolecular Bioscience (25 February 2024) has selected a paper co-authored by CSO Sakai and CTO Kamada. Preclustering Gelatin for Faster-Forming Injectable Hydrogels: A Strategy for Fabricating 3D Hydrogel Scaffolds with Improved Cell Dispersion https://lnkd.in/g5z695Ph
Media
gellycle.com